On Aug. 10, 2021, Moderna announced that it plans to build a messenger RNA (mRNA) vaccine manufacturing facility in Canada that will include access to the company’s mRNA development technology. The company signed a memorandum of understanding (MoU) with the government of Canada for the facility.
Under the MoU, Moderna and Canada aim to build a foundation on which Canada can have direct access to pandemic response capabilities as well as access to vaccines Moderna is developing against respiratory viruses, including COVID-19, seasonal influenza, respiratory syncytial virus (RSV), and potential other vaccines, pending licensure. Moderna is also in discussion with other governments for potential collaborations built on a similar model, the company stated in a press release.
